News

Alkermes will receive $166.3 million upon closing of the transaction and up to an additional $7.7 million subject to the terms and conditions of an escrow arrangement that

Phase Forward has worked with several partners and sponsors in the region for the last seven years to support several hundred hosted clinical trials. While expanding in India,

The total number of shares sold by the company included 1.8 million shares sold to the underwriters upon their exercise of their over-allotment option in full. Certain selling

Through its strategic in-licensing and development strategy, Reliant has developed a portfolio of specialty medicines combating heart disease, including US rights to Lovaza (omega-3-acid ethyl esters), a treatment

The acquisition is a two-step process. The initial E42.3 million cash payment will purchase the privately held Carli family interest in Ideal Medical Products, and then a tender

CooperVision had alleged that CIBA Vision infringed patented technologies relating to the edge design and rotational stabilization of contact lenses while CIBA Vision alleged that CooperVision infringed patented

This industrialization model is Institute of Microbiology, Chinese Academy of Sciences’s (IMCAS’s) first cooperative arrangement with a pharmaceuticals manufacturing company. Genesis will fund the industrialization model’s daily operations

The payments will be made in increments of $1 million upon the achievement of various equity financing parameters which may be met by SagaX over a four-year period

The preliminary results from the first 21 patients treated in the Phase I combination trial with cisplatin showed similar results, with 14 of the patients experiencing stable disease